News

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, announced that Randall ...
Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is revolutionizing lipid nanoparticle (LNP) analysis with ...
analysis with the launch of the ONI Application Kit™: LNP Profiler, the first and only verified solution within the SMLM and super-resolution space for particle analysis. The kit includes a ...
Setting a New Benchmark in Precision and Efficiency for LNP Analysis SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 31, 2025 / Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is ...